Research shows that spinal disc degeneration occurs when cells lose access to a nutrient called serine, causing them to age rapidly and stop maintaining the disc structure. According to Gram Research analysis, scientists discovered that restoring serine or increasing the PHGDH protein that makes serine reversed disc damage in animal models, suggesting future treatments could prevent or slow age-related back pain from disc breakdown.
Researchers have discovered why the cushioning discs in your spine break down as you age, and they found a potential way to stop it. According to Gram Research analysis, the problem starts when cells in these discs run out of a nutrient called serine, which causes them to age prematurely and stop working properly. Scientists used gene therapy to restore this nutrient in damaged discs in rats, and the discs improved significantly. This discovery could lead to new treatments for the millions of people who suffer from lower back pain caused by disc degeneration.
Key Statistics
A 2026 research study published in Advanced Science found that the PHGDH protein, which helps cells produce serine, was significantly reduced in degenerated spinal discs compared to healthy discs, linking nutrient deficiency to disc aging.
Gene therapy that increased PHGDH levels alleviated disc degeneration in rats with artificially damaged discs, while rats fed a serine-deficient diet experienced worse degeneration, demonstrating that serine availability directly controls disc health.
Research revealed that serine deprivation in spinal disc cells triggers a cascade that blocks autophagy, the cellular recycling process, while simultaneously depleting protective molecules and increasing harmful reactive oxygen species that damage cells.
The Quick Take
- What they studied: How a nutrient called serine and a protein called PHGDH affect the health of cells in spinal discs, and whether restoring these could prevent or reverse disc damage
- Who participated: Laboratory studies using human disc cells, aged rat tissues, and samples from people with damaged discs. Researchers also tested gene therapy in rats with artificially damaged discs
- Key finding: When serine levels drop in spinal disc cells, the cells age rapidly and stop producing the material that keeps discs healthy. Restoring serine or the PHGDH protein reversed this damage in animal models
- What it means for you: This research suggests that future treatments might prevent or slow disc degeneration by boosting serine levels or PHGDH activity. However, these findings are still in early stages and human treatments are not yet available
The Research Details
Scientists used multiple approaches to understand how serine metabolism affects spinal disc health. First, they analyzed gene activity in healthy and damaged disc cells to identify which genes were turned off in damaged cells. They discovered that genes involved in making serine were significantly reduced. Next, they used advanced genetic sequencing to confirm this finding in human disc samples, aged rat tissues, and degenerated human discs. To understand the mechanism, they deliberately reduced serine in cells and observed what happened. Finally, they tested a potential treatment by using gene therapy to increase PHGDH levels in rats with damaged discs and tracked whether the discs improved over time.
This multi-layered approach is important because it moves from observation to mechanism to potential treatment. By studying human tissue samples alongside animal models, the researchers could confirm their findings were relevant to real disc degeneration in people. Testing gene therapy in living animals provided evidence that the approach could actually work in a whole organism, not just in isolated cells
The study was published in Advanced Science, a peer-reviewed journal. The researchers used multiple independent methods to confirm their findings, including gene sequencing, cell culture experiments, and animal models. They examined tissue from multiple sources (human, rat, aged, and degenerated samples) to strengthen their conclusions. However, the study was conducted primarily in laboratory and animal settings, so human clinical trials are still needed to confirm these results work in people
What the Results Show
The research revealed a clear chain of events that leads to disc degeneration. When serine becomes scarce in spinal disc cells, the cells stop dividing and start aging prematurely. The PHGDH protein, which normally helps cells make serine, was found to be significantly reduced in damaged discs compared to healthy ones. When researchers artificially reduced PHGDH or serine in healthy cells, the cells showed signs of aging and stopped producing the proteins that form the disc’s structure. Most importantly, when scientists used gene therapy to increase PHGDH levels in rats with damaged discs, the discs showed significant improvement. In contrast, rats fed a diet low in serine experienced worse disc degeneration, confirming that serine availability directly affects disc health.
The study identified the specific biological pathway responsible for this damage. When serine is depleted, cells lose the ability to recycle and clean themselves through a process called autophagy. Additionally, serine deprivation reduces protective molecules called glutathione, allowing harmful molecules called reactive oxygen species to accumulate and damage cells. The research also showed that a protein called Rap1b plays a central role in this cascade, acting as a switch that determines whether cells survive or age prematurely
Previous research had identified that spinal disc cells age prematurely under stress, but the specific cause was unclear. This study provides the missing piece by showing that serine metabolism is the key driver. The findings align with growing evidence that amino acid metabolism, the process by which cells use protein building blocks, is crucial for aging and cellular health. This research extends that knowledge specifically to disc degeneration, a condition affecting millions of people
This research was conducted primarily in laboratory cells and animal models. The gene therapy approach used in rats may not translate directly to humans, and the long-term safety and effectiveness in people remain unknown. The study did not test whether dietary serine supplementation alone could prevent disc degeneration in humans. Additionally, the research focused on one specific pathway, and disc degeneration in real people likely involves multiple contributing factors. Finally, the sample sizes for some experiments were not specified, making it difficult to assess the statistical power of certain findings
The Bottom Line
Based on this research, future treatments might include serine supplementation or drugs that increase PHGDH activity. However, these approaches are not yet proven in humans and should not be attempted without medical supervision. Current evidence-based recommendations for disc health remain: maintain a healthy weight, stay physically active, practice good posture, and avoid prolonged sitting. If you have back pain, consult a healthcare provider for evaluation and treatment options
This research is most relevant to people experiencing lower back pain from disc degeneration, people with a family history of disc problems, and those interested in preventing age-related spine issues. It may also interest people with other age-related conditions, since serine metabolism affects cellular aging broadly. This research is not yet applicable to individual treatment decisions but may inform future clinical trials
If this research leads to human treatments, it will likely take 5 to 10 years for clinical trials and regulatory approval. In the shorter term, this knowledge may help researchers develop targeted therapies within 2 to 3 years. People should not expect immediate treatment options based on this discovery
Frequently Asked Questions
What causes intervertebral disc degeneration and lower back pain?
Disc degeneration occurs when cells in spinal discs age prematurely due to stress and nutrient deprivation. Research shows that low serine levels trigger this premature aging, causing cells to stop maintaining the disc structure and leading to pain and reduced mobility.
Can serine supplements prevent or treat back pain from disc degeneration?
Current research shows serine is important for disc health in laboratory and animal studies, but human clinical trials have not yet been conducted. Do not take serine supplements without consulting a doctor, as safety and effectiveness in people remain unproven.
How soon will treatments based on this research be available?
Gene therapy and serine-based treatments are still in early research stages. If development proceeds successfully, human clinical trials could begin within 2 to 3 years, with approved treatments potentially available 5 to 10 years from now.
What can I do now to protect my spinal discs from degeneration?
Maintain a healthy weight, exercise regularly with core strengthening, practice good posture, avoid prolonged sitting, and stay hydrated. These evidence-based approaches support overall spine health while researchers develop new treatments based on serine metabolism research.
Is this research applicable to all types of back pain?
This research specifically addresses disc degeneration, which is one cause of lower back pain. Other back pain causes include muscle strain, nerve compression, and structural problems. Consult a healthcare provider to determine the cause of your back pain and appropriate treatment options.
Want to Apply This Research?
- Track daily back pain levels on a 0-10 scale and note activities that worsen or improve symptoms. Record weekly physical activity minutes and posture check-ins to establish baseline habits before any future serine-based treatments become available
- Users can implement evidence-based spine health practices now: set hourly reminders to stand and stretch, log daily water intake to support cellular health, track weekly exercise focusing on core strengthening, and monitor sitting duration to limit prolonged static posture
- Establish a baseline of current back pain patterns and mobility levels. Once treatments become available, users can track changes in pain, mobility, and quality of life over weeks and months. Regular check-ins with healthcare providers should accompany any tracking to ensure safe progress
This article summarizes research findings and is not medical advice. The treatments discussed, including serine supplementation and gene therapy, are not yet approved for human use and should not be attempted without direct medical supervision. If you experience back pain or have concerns about disc degeneration, consult a qualified healthcare provider for proper diagnosis and treatment. This research is preliminary and findings from animal studies do not always translate to humans. Always discuss any new treatments or supplements with your doctor before use.
This research translation is published by Gram Research, the science division of Gram, an AI-powered nutrition tracking app.